Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Elevate Ventures
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 0.04%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
ReNewVax logoFounded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
GIVAX51-200 employees
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…
BaseimmuneFounded 2019
404 Err….or The vaccines you're looking for don't exist. Yet….
Infinitopes Precision Immunomics™Founded 2018 • 11-50 employees
Positioned to deliver revolutionary off-the-shelf cancer vaccines. OUR CORE MISSION.
Apriori BioFounded 2020
Protecting against viral threats. Ushering in a new era of AI-enabled vaccine design.
Transforming global healthcare with self-administered microneedle vaccine patches. Safe, efficient, and accessible- bringing vaccinations…

Overview

Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience, we deliver quality medicines and vaccines, complemented by diagnostic products and genetic tests and supported by a range of services.

News

News in.investing.com 8 days ago
Zoetis stock hits 52-week low at 70.97 USD Read more
Report
News sharewise 11 days ago
Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales
Key Points Interested in Zoetis Inc.? Here are five stocks we like better. Zoetis maintained its revised guidance for operational revenue declining 3% to 1%, citing weaker U.S. pet-care demand, fewer…
Read more
Report
News YahooFinance 18 days ago
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?
If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity.
Read more
Report
News The Motley Fool 4 months ago
Why Zoetis Shares Plummeted Today
Zoetis reported first-quarter earnings on Thursday, and the market did not like what it saw.
Read more
Report
Pro access
Upgrade to see all 9 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.